Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

Mammoth Bio Signs Commercialization Deal for SARS CoV-2 Test With MilliporeSigma, Hamilton Company

Oct 29, 2020
|
staff reporter

NEW YORK – Mammoth Biosciences said on Thursday that it has signed agreements with MilliporeSigma and Hamilton Company to commercialize a high-throughput, CRISPR-based SARS CoV-2 test.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

What's Popular?

In Business News

  1. Hologic Acquires European MDx Firm Diagenode for Approximately $159M

  2. Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

  3. Myriad Genetics, Intermountain Healthcare Collaborate for Cancer Testing Service

  4. William Blair Initiates Coverage of Point-of-Care MDx Firm Lucira Health With Outperform Rating

  5. OraSure Technologies Q4 Revenues Rise 27 Percent, Beat Analysts' Estimate

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.